Dale Muzzey, Ph.D.

Dale Muzzey, Ph.D.

Chief Scientific OfficeratMyriad Genetics· In proxies 2023–2025

Pay in FY2025-38% from the year before · Myriad Genetics stock -55.1% the same year

Dale Muzzey, Ph.D. was paid $1.9M in FY2025 (Dec), down 38%. Myriad Genetics stock fell 55.1% that year.

Pay$100 in the stock at the end of FY22 → $42
Pay is from the Summary Compensation Table of each Myriad Genetics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Myriad GeneticsPublic company · 3 yr
    • Chief Scientific Officer2023 – Present · 3 yrStock in role -57%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?